- Home
- ATXS vs ECX Comparison
ATXS vs ECX Comparison
Compare ATXS & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- ECX
- Stock Information
- Founded
- ATXS 2008
- ECX 2017
- Country
- ATXS United States
- ECX China
- Employees
- ATXS N/A
- ECX N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- ECX EDP Services
- Sector
- ATXS Health Care
- ECX Technology
- Exchange
- ATXS Nasdaq
- ECX Nasdaq
- Market Cap
- ATXS 669.8M
- ECX 584.9M
- IPO Year
- ATXS 2015
- ECX N/A
- Fundamental
- Price
- ATXS $9.37
- ECX $1.72
- Analyst Decision
- ATXS Strong Buy
- ECX
- Analyst Count
- ATXS 5
- ECX 0
- Target Price
- ATXS $25.60
- ECX N/A
- AVG Volume (30 Days)
- ATXS 219.2K
- ECX 22.1K
- Earning Date
- ATXS 11-13-2024
- ECX 11-07-2024
- Dividend Yield
- ATXS N/A
- ECX N/A
- EPS Growth
- ATXS N/A
- ECX N/A
- EPS
- ATXS N/A
- ECX N/A
- Revenue
- ATXS N/A
- ECX $778,608,168.00
- Revenue This Year
- ATXS N/A
- ECX N/A
- Revenue Next Year
- ATXS N/A
- ECX $39.50
- P/E Ratio
- ATXS N/A
- ECX N/A
- Revenue Growth
- ATXS N/A
- ECX 25.70
- 52 Week Low
- ATXS $4.26
- ECX $0.96
- 52 Week High
- ATXS $16.90
- ECX $3.44
- Technical
- Relative Strength Index (RSI)
- ATXS 30.44
- ECX 40.53
- Support Level
- ATXS $11.40
- ECX $1.76
- Resistance Level
- ATXS $11.75
- ECX $1.81
- Average True Range (ATR)
- ATXS 0.75
- ECX 0.07
- MACD
- ATXS -0.23
- ECX -0.01
- Stochastic Oscillator
- ATXS 7.64
- ECX 5.56
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About ECX ECARX Holdings Inc. Ordinary shares
ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.